… prospective open-label study of 173 nursing home residents with AD treated with rivastigmine
… to have limited clinical efficacy for treating depression in dementia, 37 selective serotonin …

… onset AD (EOAD) and late onset AD (LOAD), with the former mostly contributing to our
current understanding of AD … or depression. It is commonly understood that the main cause of …

… , we found evidence that oral intake of saffron by patients with AD may have … Rivastigmine
has shown some promising effects on depressive symptoms of AD patients, but further studies …

… reports suggest that ChEIs may ameliorate neuropsychiatric symptoms in Alzheimer's or Lewy
… An observational study in AD found significative cognitive advantages with vortioxetine in …

… h light/dark cycle (lights on at 6 am) with ad libitum access to food and water. Each cage had
an … of galantamine and rivastigmine from the current study, tends to promote depression-like …

… the course of cognitive decline in AD. Potential benefits of … Furthermore, long-term melatonin
use could ameliorate … of donepezil, galantamine, rivastigmine, memantine, and Namzaric for …

… -scale, 6-month study of 55 patients with mild-to-moderate AD also con… , and galantamine,
can also ameliorate the psychiatric … A 6-month, open-label study of memantine in patients with …

… so in order to ameliorate this burdensome neuropsychiatric disorder… This group also found
that the AChEIs rivastigmine and … on depression in elderly subjects who are suffering from AD, …

… and rivastigmine were beneficial for cognitive functioning in mild-to-moderate to severe
AD, although the … and AChEIs for ameliorating cognitive outcomes for people with mild-to- …

… In another 6-month, open-label study on 24 PD patients, … Finally rivastigmine 4,6 mg
bedtime patch improved RBD in 12 PD … An amelioration in hyperdopaminergic behavioral …